Highlights Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

300573

CNE100002DV1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-29 pm EDT			5-day change	1st Jan Change
204.8 ^CNY	+0.79%		+4.33%	+57.26%

May. 22	Space Peptides announced that it has received funding from Humanwell Healthcare Co.,Ltd., Shenyang Xingqi Pharmaceutical Co.,Ltd., Xiamen Furuier Pharmaceutical Co., Ltd., Purple Knight Capital and other investors	CI
Apr. 26	Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024	May. 15	CI
Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%	Apr. 26	MT
Xingqi Pharma Gets Nod to Market Atropine Sulfate Eye Drop; Shares Up 3%	Mar. 13	MT
Xingqi Pharmaceutical's Diquafosol Sodium Eye Drops Bags China's Centralized Drug Bid	Nov. 08	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Interim Dividend on A Shares for the Year 2023, Payable on 22 September 2023	23-09-18	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Interim Profit Distribution Plan for 2023	23-09-14	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Dividend for the First Half of 2023	23-08-29	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 22 May 2023	23-05-12	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Proposes Final Dividend for 2022	23-04-20	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Announces Interim Dividend on A Shares for the Year 2021, Payable on September 23, 2022	22-09-16	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Interim Cash Dividend for 2022	22-09-14	CI
Shenyang Xingqi Pharmaceutical Announces Profit Distribution Proposal for the First Half of 2022	22-08-28	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 20 May 2022	22-05-13	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2021	22-05-12	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Proposes Final Cash Dividend for the Year 2021	22-04-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

300573

CNE100002DV1

Highlights

Filters